Psychedelic therapy as a complementary treatment approach for alcohol use disorders
Peter Eischens, William Leigh Atherton
Journal of Psychedelic Studies May 30, 2018 DOI: 10.1556/2054.2018.005 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction Psychedelic-assisted therapy |
| Key findings | The authors argue that psychedelic substances may serve as a safe and clinically effective complementary approach to treating alcohol use disorders, addressing affective, cognitive, social, legal, and spiritual dimensions. They contend that traditional AUD interventions have yielded mixed outcomes and that rising global AUD rates justify exploring novel treatments. |
Abstract
Background: Traditional treatment interventions for alcohol use disorders (AUD) have produced mixed outcomes and the global increase in AUDs demands novel and innovative approaches to addiction treatment.Psychedelic substances have been reintroduced into the Western medical community as a potential intervention to complement the treatment of AUDs.Objectives: This paper will discuss the implications of using psychedelic substances as a complementary approach within the treatment of AUDs.Methods: A thorough review of pertinent research focused on the use of psychedelics in relation to the affective, cognitive, social, legal, and spiritual issues commonly associated with AUDs.Results: Research suggests the clinical efficacy and safety of psychedelic therapy as a complementary treatment for AUDs.Conclusion: Future directions and implications to AUD treatment are provided.
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cites 37
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
and 32 more in the library